Meeting
2017 Gastrointestinal Cancers Symposium
Effect of extending the original eligibility criteria for the “CROSS” neoadjuvant chemoradiotherapy on toxicity and survival in esophageal cancer.
Authors
Jan-Binne Hulshoff
University of Groningen, University Medical Center Groningen, Department of Surgical Oncology, Groningen, Netherlands
Jan-Binne Hulshoff , Ellen C. de Heer , Daphne H. Klerk , Derk Jan De Groot , John Theodorus Plukker , Geke Hospers
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 187)
DOI
10.1200/JCO.2017.35.4_suppl.187
Abstract #
187
Poster Bd #
M13
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Toxicity and survival in older versus younger esophageal cancer (EC) patients (pts) treated with neoadjuvant chemoradiotherapy (nCRT).
First Author: Rishi Jain
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling survival strategies: The impact of treatment modalities on patients with esophageal cancer and the role of racial disparities.
First Author: Dani Ran Castillo
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Neoadjuvant chemoradiation in elderly Irish patients with esophageal cancer: A review of the clinical outcomes and toxicity.
First Author: Ronan Andrew Mc Laughlin
Poster
2017 ASCO Annual Meeting
Patterns of care and treatment outcomes of patients with stage I esophageal cancer: A National Cancer Database analysis.
First Author: Amy Catherine Moreno